Abbott Laboratories (ABT)

USD 111.93

(-1.2%)

Net Income Summary of Abbott Laboratories

  • Abbott Laboratories's latest annual net income in 2023 was 5.72 Billion USD , down -17.45% from previous year.
  • Abbott Laboratories's latest quarterly net income in 2024 Q3 was 1.64 Billion USD , up 26.42% from previous quarter.
  • Abbott Laboratories reported an annual net income of 6.93 Billion USD in 2022, down -1.95% from previous year.
  • Abbott Laboratories reported an annual net income of 7.07 Billion USD in 2021, up 57.31% from previous year.
  • Abbott Laboratories reported a quarterly net income of 1.22 Billion USD for 2024 Q1, down -23.15% from previous quarter.
  • Abbott Laboratories reported a quarterly net income of 1.64 Billion USD for 2024 Q3, up 26.42% from previous quarter.

Annual Net Income Chart of Abbott Laboratories (2023 - 1989)

Historical Annual Net Income of Abbott Laboratories (2023 - 1989)

Year Net Income Net Income Growth
2023 5.72 Billion USD -17.45%
2022 6.93 Billion USD -1.95%
2021 7.07 Billion USD 57.31%
2020 4.49 Billion USD 21.91%
2019 3.68 Billion USD 55.7%
2018 2.36 Billion USD 396.44%
2017 477 Million USD -65.93%
2016 1.4 Billion USD -68.35%
2015 4.42 Billion USD 93.65%
2014 2.28 Billion USD -11.34%
2013 2.57 Billion USD -56.8%
2012 5.96 Billion USD 26.12%
2011 4.72 Billion USD 2.2%
2010 4.62 Billion USD -19.49%
2009 5.74 Billion USD 17.73%
2008 4.88 Billion USD 35.34%
2007 3.6 Billion USD 110.07%
2006 1.71 Billion USD -49.09%
2005 3.37 Billion USD 4.21%
2004 3.23 Billion USD 17.53%
2003 2.75 Billion USD -1.45%
2002 2.79 Billion USD 80.19%
2001 1.55 Billion USD -44.35%
2000 2.78 Billion USD 13.91%
1999 2.44 Billion USD 4.77%
1998 2.33 Billion USD 12.28%
1997 2.07 Billion USD 10.47%
1996 1.88 Billion USD 11.45%
1995 1.68 Billion USD 11.34%
1994 1.51 Billion USD 8.4%
1993 1.39 Billion USD 12.91%
1992 1.23 Billion USD 13.8%
1991 1.08 Billion USD 12.74%
1990 965.8 Million USD 12.33%
1989 859.8 Million USD 14.34%

Peer Net Income Comparison of Abbott Laboratories

Name Net Income Net Income Difference
Allurion Technologies Inc. -82.3 Million USD 7053.49%
Artivion, Inc. -30.69 Million USD 18747.768%
Avanos Medical, Inc. -61.8 Million USD 9360.518%
Butterfly Network, Inc. -133.69 Million USD 4380.479%
Butterfly Network, Inc. -133.69 Million USD 4380.479%
Bio-Rad Laboratories, Inc. -637.32 Million USD 997.973%
Boston Scientific Corporation 1.59 Billion USD -259.259%
Perspective Therapeutics, Inc. -14.67 Million USD 39111.588%
CONMED Corporation 64.45 Million USD -8778.512%
Edwards Lifesciences Corporation 1.4 Billion USD -308.086%
Paragon 28, Inc. -47.84 Million USD 12062.543%
Glaukos Corporation -134.66 Million USD 4349.931%
Globus Medical, Inc. 122.87 Million USD -4557.655%
Inspire Medical Systems, Inc. -21.15 Million USD 27155.264%
Integer Holdings Corporation 90.65 Million USD -6213.293%
Medtronic plc 3.67 Billion USD -55.686%
Nevro Corp. -92.21 Million USD 6306.283%
Owlet, Inc. -32.9 Million USD 17494.608%
Penumbra, Inc. 90.95 Million USD -6192.192%
Vicarious Surgical Inc. -71.07 Million USD 8152.511%
Smith & Nephew plc 263 Million USD -2076.046%
Sonendo, Inc. -60.91 Million USD 9494.442%
STERIS plc 378.23 Million USD -1413.064%
Stryker Corporation 3.16 Billion USD -80.821%
Vapotherm, Inc. -58.19 Million USD 9934.516%
Zimmer Biomet Holdings, Inc. 1.02 Billion USD -458.887%